3P¨otzschB,MadfenerK,SeelingC ,etal.Monitoringofr hirudinantico agulationduringcardiopulmonarybypass:assessmentofthewholebloodecarinclottingtime[].Thrombosis and Haemostasis.1997
4P¨otzschB,KlovekornWP,MadlenerK.Useofheparinduringcardiopul monarybypassinpatientswithahistoryofheparin inducedthrombocytope nia[].The New England Journal of Medicine.2001
5Weitz JI.Low-molecular-weight heparin[].The New England Journal of Medicine.1997
6Fernandes P,Mayer R,MacDonald JL,et al.Use of danaparoid sodium(orgaran) as an alternative to heparin sodium during cardiopulmonary bypass: a clinical evaluation of six cases[].Perfusion.2000
7Wilhelm MJ,Schmid C,Kececioglu D,et al.Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using org 10172[].The Annals of Thoracic Surgery.1996
8Robin R,Kanagasabay FM,Jonathan UW,et al.Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia[].The Annals of Thoracic Surgery.1998
9Frederiksen JW.Cardiopulmonary bypass in humans: bypassing unfractionated heparin[].The Annals of Thoracic Surgery.2000
10Gitlin SD,Deeb GM,Yann C,et al.Interoperative monitoring of danaparoid sodium anticoagulation during cardiovascular operations[].Journal of Vascular Surgery.1998
